Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000023

Chief Financial Officer sold 62,774 shares at an average $105.46 ($6,619,913)

  • Chief Financial Officer acquired 57,187 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2026-08-31 Option exercise 10b5-1 +57,187 $25.79 $1,474,853 176,798 D: show line 1 in the form
Smith Hunter C Chief Financial Officer 2026-08-31 Sale 10b5-1 −23,072 $104.59 $2,413,034 153,726 D: show line 2 in the form
Smith Hunter C Chief Financial Officer 2026-08-31 Sale 10b5-1 −11,514 $105.37 $1,213,232 142,212 D: show line 3 in the form
Smith Hunter C Chief Financial Officer 2026-08-31 Sale 10b5-1 −28,188 $106.20 $2,993,647 114,024 D: show line 4 in the form
Open-market sales · 62,774 sh · avg $105.46 · $6,619,913

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Smith Hunter C Chief Financial Officer 2026-08-31 Option exercise · Employee Stock Option (Right to Buy) 10b5-1 −57,187 3,813 D: show line 5 in the form
Loading xslF345X06/form4.xml…